Oncology Institute, Inc. financial data

Symbol
TOI, TOIIW on Nasdaq, DFPH on OTC
Location
18000 Studebaker Rd, Suite 800, Cerritos, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 197 % -47.2%
Quick Ratio 21.6 % -34.4%
Debt-to-equity 4.36K % +1319%
Return On Equity -1.74K % -1112%
Return On Assets -39 % -10.6%
Operating Margin -11.1 % +37.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 93.5M shares +23.9%
Common Stock, Shares, Outstanding 93.3M shares +23.6%
Entity Public Float 34.9M USD -16.1%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 93.2M shares +24.7%
Weighted Average Number of Shares Outstanding, Diluted 93.2M shares +24.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 424M USD +17.5%
Operating Income (Loss) -46.9M USD +26.2%
Nonoperating Income (Expense) -19.1M USD -134%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -66M USD +7.95%
Income Tax Expense (Benefit) -131K USD +26.8%
Net Income (Loss) Attributable to Parent -65.9M USD +7.9%
Earnings Per Share, Basic 0 USD/shares +13.9%
Earnings Per Share, Diluted 0 USD/shares +13.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 55.7M USD +3.04%
Inventory, Net 15.8M USD +39.4%
Assets, Current 105M USD -9.83%
Property, Plant and Equipment, Net 10.9M USD -11.3%
Operating Lease, Right-of-Use Asset 23.9M USD -11.5%
Intangible Assets, Net (Excluding Goodwill) 12.4M USD -23.9%
Goodwill 7.23M USD 0%
Other Assets, Noncurrent 586K USD +0.69%
Assets 160M USD -11%
Accounts Payable, Current 34.9M USD +122%
Employee-related Liabilities, Current 5.47M USD +6.05%
Accrued Liabilities, Current 22.9M USD +78.4%
Contract with Customer, Liability, Current 5.2M USD +504%
Liabilities, Current 64.8M USD +84.5%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 21.2M USD -13.7%
Other Liabilities, Noncurrent 10K USD -94.4%
Liabilities 169M USD +12.2%
Retained Earnings (Accumulated Deficit) -247M USD -36.3%
Stockholders' Equity Attributable to Parent -8.99M USD -131%
Liabilities and Equity 160M USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.99M USD +68.6%
Net Cash Provided by (Used in) Financing Activities -4.74M USD -405%
Net Cash Provided by (Used in) Investing Activities -202K USD -101%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 95M shares +23%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.3M USD -16.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.29M USD +13.8%
Deferred Tax Assets, Valuation Allowance 63.6M USD +17.8%
Deferred Tax Assets, Gross 72.8M USD +13.4%
Operating Lease, Liability 28.1M USD -9.42%
Depreciation 3.78M USD +18.6%
Payments to Acquire Property, Plant, and Equipment 328K USD -46.2%
Lessee, Operating Lease, Liability, to be Paid 32.7M USD -11.1%
Operating Lease, Liability, Current 6.95M USD +6.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.26M USD -4.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.4M USD +3.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.61M USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.28M USD -15.9%
Deferred Tax Assets, Operating Loss Carryforwards 53.4M USD +32.4%
Preferred Stock, Shares Issued 194K shares +17.4%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 99K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.72M USD -12.9%
Operating Lease, Payments 2.21M USD +7.98%
Additional Paid in Capital 239M USD +13.1%
Preferred Stock, Shares Outstanding 194K shares +17.4%
Amortization of Intangible Assets 3.09M USD -0.23%
Depreciation, Depletion and Amortization 1.78M USD +19.8%
Deferred Tax Assets, Net of Valuation Allowance 9.19M USD -9.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%